Related Experiment Video
Updated: Jun 5, 2026

06:07
Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
Published on: June 7, 2020
High content imaging-based assay to classify estrogen receptor-α ligands based on defined mechanistic outcomes
F J Ashcroft1, J Y Newberg, E D Jones
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Gene
|January 25, 2011
Summary
We developed a new assay to study estrogen receptor-alpha (ER) activity and its response to chemicals. This method provides detailed insights into how compounds affect ER function, aiding drug discovery and understanding environmental toxins.
Area of Science:
- Endocrinology
- Molecular Biology
- Toxicology
Background:
- Estrogen receptor-alpha (ER) is a key target for drugs and endocrine disrupting chemicals (EDCs).
- Understanding how chemicals modulate ER transcriptional activity is crucial but remains poorly understood.
- Existing methods lack the resolution to fully elucidate these complex mechanisms.
Purpose of the Study:
- To develop a novel high-content assay for detailed analysis of ER transcriptional activity.
- To provide new mechanistic insights into the actions of ER ligands and EDCs.
- To establish a versatile platform for both basic research and drug screening.
Main Methods:
- Development of a high-content analysis assay utilizing a microscopically visible, multi-copy integration of an ER-regulated promoter.
- Automated single-cell analyses to quantify promoter occupancy, cofactors recruitment, and chromatin modifications.
- Multi-parametric data analysis for high-resolution classification of ligand responses.
Main Results:
- The assay successfully quantified ER activity and its modulation by various ligands and EDCs at the single-cell level.
- Simultaneous measurement of promoter occupancy, cofactor recruitment, and chromatin changes provided comprehensive mechanistic data.
- High-resolution classification of ligand responses was achieved using image-derived multi-parametric data.
Conclusions:
- The developed assay represents a novel technology for studying ER activity.
- This system offers new mechanistic insights into the effects of EDCs and therapeutic compounds.
- The assay is suitable for both fundamental mechanistic investigations and drug testing applications.
